Status:
COMPLETED
Epidural Neostigmine for Labor Pain
Lead Sponsor:
Wake Forest University
Conditions:
Labor Pain
Eligibility:
FEMALE
18-50 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to see which dose of epidural neostigmine is the best additive to use with the numbing medication used in an epidural during labor.
Detailed Description
This study is examining the use of the non-narcotic medication, neostigmine, in combination with the local anesthetic bupivacaine when compared with the commonly used narcotic fentanyl in providing pa...
Eligibility Criteria
Inclusion
- Healthy pregnancy
- Term pregnancy ( \> 37 weeks)
- Primiparous or multiparous
- Induction or spontaneous labor greater or = 18 years of age
- Cervical exam on entry \</=5 cm
Exclusion
- Weight \> 115 kg
- Non-English speaking
- IV analgesics within 60 minutes prior to epidural being administered
- Allergy to local anesthetics or neostigmine
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2013
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00779467
Start Date
October 1 2008
End Date
November 1 2013
Last Update
September 11 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Forsyth Medical Center
Winston-Salem, North Carolina, United States, 27103